Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires
In response to the critical need for safe storage and charging of lithium-ion batteries, Justrite announces the launch of its...
MedEquipment Trends
Bot Image, Inc. introduced its Prostate Cancer detection, diagnosis, and screening software at urologist meeting in San Antonio, Texas
Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company (www.botimageai.com), introduced its Prostate Cancer detection, diagnosis, and screening software to...
Penumbra Launches Lightning Flash 2.0 – Latest CAVT Technology Designed to Rapidly Remove Blood Clots
Penumbra, Inc. (NYSE: PEN), the world's largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA) clearance and launch...
FDA Grants HemoSonics Expanded Use of its Critical Bleeding Management System with Special 510(k) Clearance
HemoSonics, a medical device company focused on acute bleeding management, today announced it has received Special 510(k) clearance from the...
NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use
Kelyniam Global (OTC:KLYG) and Fin-ceramica, Faenza S.p.a., makers of custom cranial implants, announced today that the NEOS Surgery Cranial LOOP™...
New Knee Research Finds Exactech Technologies Improve Patient Outcomes
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced new research that reports...
Mediwave Wins Global Recognition at GLOMO Awards 2024 for Health Technologies for Emergency Response
Mediwave, a leading health technology company, has been recognized as a finalist in the prestigious Global Mobile Awards (GLOMO), part...
Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced...
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second...
Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
